The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
出版年份 2022 全文链接
标题
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-05-12
DOI
10.3389/fonc.2022.899145
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
- (2021) Xianglan Yi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
- (2021) Wen (Jess) Li et al. Frontiers in Cell and Developmental Biology
- Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression
- (2021) Wei-Xian Chen et al. Aging-US
- Targeting Signaling Pathway Networks in Several Malignant Tumors: Progresses and Challenges
- (2021) Hongdan He et al. Frontiers in Pharmacology
- Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity
- (2020) Wang Yadi et al. BMC Cardiovascular Disorders
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing
- (2020) Yue Zhang et al. PeerJ
- Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin
- (2020) Sonia Gioffré et al. Journal of Clinical Medicine
- Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets
- (2020) Hong-ge Fa et al. ACTA PHARMACOLOGICA SINICA
- miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
- (2020) Hui Zhang et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer
- (2020) Jie Hao et al. JOURNAL OF SURGICAL RESEARCH
- miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2
- (2019) Ying Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
- (2019) Yi Zhang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells
- (2019) Di Hu et al. Genetic Testing and Molecular Biomarkers
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
- (2019) Iris C. Salaroglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway
- (2019) Hong Dai et al. BIOSCIENCE REPORTS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Resveratrol chemosensitizes adriamycin‐resistant breast cancer cells by modulating miR‐122‐5p
- (2019) Wei Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Research advances in the detection of miRNA
- (2019) Jiawei Ye et al. Journal of Pharmaceutical Analysis
- circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
- (2019) Yiran Liang et al. ONCOGENE
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
- (2019) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
- (2019) Feiya Du et al. Cell Death & Disease
- microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2
- (2018) Huijuan Zeng et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
- (2018) Pierre Frères et al. BMC CANCER
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Novel prognostic and predictive microRNA targets for triple-negative breast cancer
- (2018) Gulisa Turashvili et al. FASEB JOURNAL
- SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
- (2018) Xu Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
- (2018) Hailong Mi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
- (2018) Mustafa Kahraman et al. Scientific Reports
- Correlation of circulating pro-angiogenic miRNAs with cardiotoxicity induced by epirubicin/cyclophosphamide followed by docetaxel in patients with breast cancer
- (2018) Xiantao Qin et al. Cancer Biomarkers
- Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer
- (2018) Marcus D. Goncalves et al. NEW ENGLAND JOURNAL OF MEDICINE
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin
- (2018) Baojuan Han et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
- (2017) Hongyu Shen et al. GENE
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- P53-miR-191- SOX4 regulatory loop affects apoptosis in breast cancer
- (2017) Shivani Sharma et al. RNA
- miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade
- (2016) Jiaxuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- β-adrenergic receptor signalling and its functional consequences in the diseased heart
- (2016) Aref Najafi et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression
- (2016) Dan-dan Wang et al. GENE
- Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
- (2016) Mengjie Rui et al. International Journal of Nanomedicine
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 non-small cell lung cancer cell line
- (2016) Qi An et al. Molecular Medicine Reports
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
- (2016) Shengpeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
- (2016) Z Deng et al. ONCOGENE
- miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
- (2016) Dan-dan Wang et al. TUMOR BIOLOGY
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
- (2016) Shanliang Zhong et al. Oncotarget
- Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
- (2016) Vagner Oliveira-Carvalho Rigaud et al. Oncotarget
- Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer
- (2016) Dong-Xu He et al. Scientific Reports
- Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2015) Jianxin Lv et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Mechanisms of breast cancer resistance to anthracyclines or taxanes
- (2015) Xiu Juan Li et al. CURRENT OPINION IN ONCOLOGY
- MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer
- (2015) Eduardo Tormo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
- (2015) Yu Sun et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs
- (2015) Ling Mao et al. TUMOR BIOLOGY
- The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer
- (2015) Xiaohong Xie et al. TUMOR BIOLOGY
- Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
- (2015) L Roca-Alonso et al. Cell Death & Disease
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1
- (2015) Jingpei Long et al. Biomed Research International
- Function of Slit/Robo signaling in breast cancer
- (2015) Feng Gu et al. Frontiers of Medicine
- Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
- (2015) Y. Fang et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2
- (2015) Yuan Yuan et al. PLoS One
- Down-regulation of miRNA-452 is Associated with Adriamycin-resistance in Breast Cancer Cells
- (2014) Qing Hu et al. Asian Pacific Journal of Cancer Prevention
- Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer
- (2014) Xiongwei Deng et al. BIOMATERIALS
- Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAcN-deacetylase/N-sulfotransferase-1 in human breast cancer
- (2014) Dong-Xu He et al. FEBS Journal
- MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
- (2014) Li Jiang et al. FEBS LETTERS
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs
- (2014) Wei-xian Chen et al. PLoS One
- Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
- (2014) Qian Li et al. PLoS One
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
- (2013) Ying Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells
- (2013) Shanliang Zhong et al. GENE
- A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling
- (2013) Jihong Yang et al. HEART FAILURE REVIEWS
- Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin
- (2013) VASYL F. CHEKHUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1and p16INK4a
- (2013) Simona Giglio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1
- (2013) GE YANG et al. ONCOLOGY REPORTS
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Breast Cancer Treatment and Adverse Cardiac Events: What Are the Molecular Mechanisms
- (2012) Laura Roca-Alonso et al. CARDIOLOGY
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- Mitochondrial recoupling: a novel therapeutic strategy for cancer?
- (2011) G Baffy et al. BRITISH JOURNAL OF CANCER
- Notch signaling: simplicity in design, versatility in function
- (2011) E. R. Andersson et al. DEVELOPMENT
- Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells
- (2010) Q-Q Li et al. CELL DEATH AND DIFFERENTIATION
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- MicroRNAs: Small RNAs With Big Effects
- (2010) Dany Anglicheau et al. TRANSPLANTATION
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2009) Guo-Qing Chen et al. MEDICAL ONCOLOGY
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started